Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.

Related Keywords

United States ,San Diego ,California ,Norway ,Houston ,Texas ,American ,Norwegian ,Cherie Duvall Jones ,Ezekiel Emanuel ,Jennifer Litton ,Edward Cliff ,Journal Of The American Medical Association ,University Of Pennsylvania ,Harvard Medical School We ,American Association For Cancer Research ,Drug Administration ,Md Anderson Cancer Center ,American Medical Association ,American Association ,Cancer Research ,Harvard Medical School ,Cancer Center ,